Compliance with DMPA contraceptive injection repeat visits during the Covid 19 pandemic

Authors

  • Gita Nirmala Sari Health Polytechnic Ministry of Health Jakarta 3, Jakarta https://orcid.org/0000-0003-3165-6005
  • Ananda Putri Setiawan Health Polytechnic Ministry of Health Jakarta 3, Jakarta
  • Novita Rina Antarsih Health Polytechnic Ministry of Health Jakarta 3, Jakarta
  • Yulia Sari Health Polytechnic Ministry of Health Jakarta 3, Jakarta
  • Yudhia Fratidhina Health Polytechnic Ministry of Health Jakarta 3, Jakarta
  • Li Yuting School of Public Health, Guangdong Pharmaceutical University, Guangzhou
  • Eprila Eprila Health Polytechnic Ministry of Health Palembang, Palembang

DOI:

https://doi.org/10.31101/jhtam.2677
Abstract views 537 times

Keywords:

DMPA injection, Family planning compliance, Husband`s support

Abstract

The 3-month of DMPA injectable contraceptive is one of the contraceptive methods that has decreased in the number of users during the Covid-19 pandemic. Acceptors of 3-month injectable contraceptives who do not comply with visits can reduce effectiveness and increase the risk of pregnancy. This study aims to examine the factors that influence the adherence of 3-month DMPA injection family planning acceptors during the Covid-19 pandemic. This was quantitative research with cross sectional design. The sample used in this study were 125 acceptors of 3-month DMPA injection family planning. Data was obtained by using a questionnaire. The analysis was performed using logistic regression. Based on multivariate analysis, there were 3 factors associated to adherence to DMPA injection repeat visits, namely family planning acceptor occupation　(OR=0.11, 95%CI= 0.04-0.31), knowledge (OR=3.59, 95%CI=1.34-9.58) and husband's support (OR=5.84, 95%CI=2.42-14.08). The most dominant factor was husband's support (OR=6.65, 95%CI=2.51-21.46). Husband's support is the most important factor that is strongly associated to injection repeat visits for DMPA family planning acceptors during the covid 19 pandemic. Good communication between partners is needed to increase DMPA injection repeat visits.

Author Biography

Gita Nirmala Sari, Health Polytechnic Ministry of Health Jakarta 3, Jakarta

Midwifery deparment

References

Akamike, I. C., Madubueze, U. C., Okedo-Alex, I. N., Anyigor, C. J., Azuogu, B. N., Umeokonkwo, C. D., & Mbachu, C. O. (2020). Perception, pattern of use, partner support and determinants of uptake of family planning methods among women in rural communities in Southeast Nigeria. Contraception and Reproductive Medicine, 5(1), 1–8. https://doi.org/10.1186/s40834-020-00120-x

Al-Sheyab, N. A., Al Nsour, M., Khader, Y. S., Yousif, H., Alyahya, M. S., Taha, H., Bardus, M., Al Kattan, M., & Amiri, M. (2021). Midwives and women’s perspectives on family planning in Jordan: human rights, gender equity, decision-making and power dynamics. Heliyon, 7(8), e07810. https://doi.org/10.1016/j.heliyon.2021.e07810

Aman, Sami, & Seema. (2019). Depot medroxy progesterone acetate (DMPA): Its acceptance, compliance and factors influencing continuation rates among women attending Lal Ded Hospital in Kashmir. Journal of Medical Science and Clinical, 7(12), 314–319.

Baumann, Lhaki, & Burke. (2019). Assessing the role of caste/ethnicity in predicting menstrual knowledge, attitudes, and practices in Nepal. Global Public Health, 14(9), 1–14.

Burke, H. M., Chen, M., Buluzi, M., Fuchs, R., Wevill, S., Venkatasubramanian, L., Santo, L. D., & Ngwira, B. (2019). Factors affecting continued use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC): A secondary analysis of a 1-year randomized trial in Malawi. Global Health Science and Practice, 7(1), 54–65. https://doi.org/10.9745/GHSP-D-18-00433

Burlando, Flynn, Gutman, McAllister, Roe, Schreiber, & Sonalkar. (2021). The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic. Obstetrics and Gynecology, 138(4), 574–577. https://doi.org/10.1097/AOG.0000000000004524

D’Exelle, B., & Ringdal, C. (2022). Women’s use of family planning services: An experiment on the husband’s involvement. Journal of Development Economics, 158(June 2021), 102915. https://doi.org/10.1016/j.jdeveco.2022.102915

Fonseca, Deshmukh, & Kharat. (2017a). DMPA: acceptance and compliance in a tertiary care hospital in Mumbai, India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 6(9), 3879. https://doi.org/10.18203/2320-1770.ijrcog20174026

Fonseca, M., Deshmukh, P. Y., & Kharat, D. (2017b). DMPA: acceptance and compliance in a tertiary care hospital in Mumbai, India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 6(9), 3879. https://doi.org/10.18203/2320-1770.ijrcog20174026

Hassan, R., Bhatia, A., Zinke-Allmang, A., Shipow, A., Ogolla, C., Gorur, K., & Cislaghi, B. (2022). Navigating family planning access during Covid-19: A qualitative study of young women’s access to information, support and health services in peri-urban Nairobi. SSM - Qualitative Research in Health, 2(December 2021), 100031. https://doi.org/10.1016/j.ssmqr.2021.100031

Herawati, Fitriana, Rosyada, Pratiwi, D., & Wigati, N. (2020). Family Planning Services by Mandiri Midwife Practices in Yogyakarta During the Pandemic Period of Covid-19. Jurnal Ilmu Kesehatan Masyarakat, 11(2), 123–135. https://doi.org/10.26553/jikm.2020.11.2.123-135

KFF. (2020). DMPA Contraceptive Injection: Use and Coverage | KFF. KFF Women`s Health Policy. https://www.kff.org/womens-health-policy/fact-sheet/dmpa-contraceptive-injection-use-and-coverage/

Kriel, Milford, Cordero, Suleman, Beksinska, Steyn, & Smit. (2019). Male partner influence on family planning and contraceptive use: Perspectives from community members and healthcare providers in KwaZulu-Natal, South Africa. Reproductive Health, 16(1), 1–15. https://doi.org/10.1186/s12978-019-0749-y

Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., Abdollahpour, I., Abdulkader, R. S., Abebe, M., Abebe, Z., Abil, O. Z., Aboyans, V., Abrham, A. R., Abu-Raddad, L. J., Abu-Rmeileh, N. M. E., … Murray, C. J. L. (2018). Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1859–1922. https://doi.org/10.1016/S0140-6736(18)32335-3

Ogidi, C. I., Okere, A. U., Ogbuabor, S. E., Nwadike, A. N., Usen, S. A., Onumonu, A. J., Ozoemena, L. C., Edeh, N. C., & Egwim, C. E. (2019). Knowledge and Use of Birth Control Methods for Family Planning by Married People in Nsukka Education Zone of Enugu State. Global Journal of Health Science, 11(8), 96. https://doi.org/10.5539/gjhs.v11n8p96

Osinowo, K., Sambo-Donga, F., Ojomo, O., Ibitoye, S. E., Oluwayemi, P., Okunfulure, M., Ladipo, O. A., & Ekholuenetale, M. (2021). Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era. Open Access Journal of Contraception, Volume 12(December), 187–199. https://doi.org/10.2147/oajc.s326106

Prata, Bell, Fraser, & Carvalho. (2017). Partner support for family planning and modern contraceptive use in Luanda , Angola. African Journal of Reproductive Health, 21(2), 35–48.

Roy, N., Amin, M. B., Maliha, M. J., Sarker, B., Aktarujjaman, M., Hossain, E., & Talukdar, G. (2021). Prevalence and factors associated with family planning during COVID-19 pandemic in Bangladesh: A cross-sectional study. PLoS ONE, 16(9 September), 1–14. https://doi.org/10.1371/journal.pone.0257634

UNFPA. (2018). Humanitarian Action 2018 Overview. In United Nation Population Fund. https://www.unfpa.org/sites/default/files/pub-pdf/

UNFPA. (2020a). Humanitarian action 2021 overview. In United Nations Population Fund. https://www.unfpa.org/sites/default/files/pub-pdf/PAGES-

UNFPA_HAO2021_Report_Updated_6_Dec.pdf

UNFPA. (2020b). Impact of COVID-19 on access to contraceptives in the LAC Region (Issue August). https://www.rhsupplies.org/uploads/tx_rhscpublications/Impact_of_COVID_19_on_the_access_to_contraceptives_in_LAC_countries.pdf

United Nations - Department of Economic and Social Affairs. (2019). Contraceptive Use by Method 2019 - Data Booklet. In Contraception Use by Method 2019 (p. 25). https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2020/Jan/un_2019_contraceptiveusebymethod_databooklet.pdf

Downloads

Published

2022-12-15

How to Cite

Sari, G. N., Setiawan, A. P., Antarsih, N. R., Sari, Y., Fratidhina, Y., Yuting, L., & Eprila, E. (2022). Compliance with DMPA contraceptive injection repeat visits during the Covid 19 pandemic. Journal of Health Technology Assessment in Midwifery, 5(2), 102–108. https://doi.org/10.31101/jhtam.2677

Issue

Vol. 5 No. 2 (2022): November

Section

Articles

License

Authors who publish with Journal of Health Technology Assessment in Midwifery agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Lisensi Creative Commons
Journal of Health Technology Assessment in Midwifery is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License..

SHARE THIS

Most read articles by the same author(s)